RESUMO
AIM: For previously untreated patients (PUPs) with severe haemophilia A in Finland for the past 2 decades, the standard practice has been to start early primary prophylaxis. We evaluated the long-term clinical outcomes and costs of treatment with high-dose prophylaxis in PUPs from birth to adolescence, including immune tolerance induction (ITI). METHODS: From the medical records of all PUPs born between June 1994 and May 2013 in Finland, we retrospectively extracted data on clinical outcomes and healthcare use. Using linear mixed models, we analysed longitudinal clinical outcome data. To analyse skewed cost data, including zero costs, we applied hurdle regression. RESULTS: All 62 patients received early regular prophylaxis; totally, they have had treatment for nearly 700 patient-years. The median age of starting home treatment was 1.1 years. The mean (SD) annual treatment costs ( per kg) were 4391 (3852). For ages 1-3, ITI comprised over half of the costs; in other groups, prophylactic FVIII treatment dominated. With these high costs, however, clinical outcomes were desirable; median (IQR) ABR was low at 0.19 (0.07-0.46) and so was AJBR at 0.06 (0-0.24). Thirteen (21%) patients developed a clinically significant inhibitor, 10 (16%) with a high titre. All ITIs were successful. The mean costs for ITI were 383 448 (259 085). The expected ITI payback period was 1.81 (95% CI 0.62-12.12) years. CONCLUSIONS: Early high-dose prophylaxis leads to excellent long-term clinical outcomes, and early childhood ITI therapy seems to turn cost-neutral generally already in 2 years.
Assuntos
Hemofilia A/tratamento farmacológico , Hemofilia A/economia , Adolescente , Criança , Pré-Escolar , Documentação , Fator VIII/economia , Fator VIII/imunologia , Fator VIII/uso terapêutico , Feminino , Finlândia , Custos de Cuidados de Saúde/estatística & dados numéricos , Hemofilia A/imunologia , Humanos , Tolerância Imunológica , Lactente , Recém-Nascido , Masculino , Resultado do TratamentoRESUMO
We study the response of a finite-sized nanoparticle array to an incident field in the vicinity of the Γ-point of the lattice. Using the coupled dipole approximation, we find that the dipole distributions can be strongly inhomogeneous and that strong modulations appear as the energy is above the Γ-point. We highlight how this is reflected in real-space extinction efficiencies as well as in radiation patterns from the finite-sized array.This article is part of the themed issue 'New horizons for nanophotonics'.
RESUMO
Lasing at the nanometre scale promises strong light-matter interactions and ultrafast operation. Plasmonic resonances supported by metallic nanoparticles have extremely small mode volumes and high field enhancements, making them an ideal platform for studying nanoscale lasing. At visible frequencies, however, the applicability of plasmon resonances is limited due to strong ohmic and radiative losses. Intriguingly, plasmonic nanoparticle arrays support non-radiative dark modes that offer longer life-times but are inaccessible to far-field radiation. Here, we show lasing both in dark and bright modes of an array of silver nanoparticles combined with optically pumped dye molecules. Linewidths of 0.2 nm at visible wavelengths and room temperature are observed. Access to the dark modes is provided by a coherent out-coupling mechanism based on the finite size of the array. The results open a route to utilize all modes of plasmonic lattices, also the high-Q ones, for studies of strong light-matter interactions, condensation and photon fluids.
RESUMO
Health care decision-making requires evidence of the cost-effectiveness of medical therapies. We evaluated the cost-effectiveness of exercise-based cardiac rehabilitation (ECR) implemented according to guidelines. All the patients (n = 204) had experienced a recent acute coronary syndrome and were randomized to a 1-year ECR (n = 109) or usual care (UC) group (n = 95). The patients' health-related quality of life was followed using the 15D instrument and health care costs were collected from electronic health registries. The cost-effectiveness of ECR was estimated based on intervention and health care costs and quality-adjusted life years (QALYs) gained. The total average cost per patient was lower in ECR than in UC. The incremental cost was divided by the baseline-adjusted incremental QALYs (0.045), yielding an incremental cost-effectiveness ratio of -24511/QALYs. A combined endpoint of mortality, recurrent coronary event, or hospitalization for a heart failure occurred for five patients in ECR and 16 patients in UC (HR 3.9, 95% CI 1.4-10.6, P = 0.004, relative risk reduction 73%, number needed to treat eight). ECR is a dominant treatment option and decreases the occurrence of adverse cardiac events. These results are useful for decision-making when planning optimal utilization of resources in Finnish health care.
Assuntos
Síndrome Coronariana Aguda/terapia , Reabilitação Cardíaca/economia , Terapia por Exercício , Síndrome Coronariana Aguda/economia , Idoso , Reabilitação Cardíaca/métodos , Análise Custo-Benefício , Feminino , Custos de Cuidados de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Qualidade de Vida , Anos de Vida Ajustados por Qualidade de VidaRESUMO
We study spatial coherence properties of a system composed of periodic silver nanoparticle arrays covered with a fluorescent organic molecule (DiD) film. The evolution of spatial coherence of this composite structure from the weak to the strong coupling regime is investigated by systematically varying the coupling strength between the localized DiD excitons and the collective, delocalized modes of the nanoparticle array known as surface lattice resonances. A gradual evolution of coherence from the weak to the strong coupling regime is observed, with the strong coupling features clearly visible in interference fringes. A high degree of spatial coherence is demonstrated in the strong coupling regime, even when the mode is very excitonlike (80%), in contrast to the purely localized nature of molecular excitons. We show that coherence appears in proportion to the weight of the plasmonic component of the mode throughout the weak-to-strong coupling crossover, providing evidence for the hybrid nature of the normal modes.
RESUMO
We show strong coupling involving three different types of resonances in plasmonic nanoarrays: surface lattice resonances (SLRs), localized surface plasmon resonances on single nanoparticles, and excitations of organic dye molecules. The measured transmission spectra show splittings that depend on the molecule concentration. The results are analyzed using finite-difference time-domain simulations, a coupled-dipole approximation, coupled-modes models, and Fano theory. The delocalized nature of the collective SLR modes suggests that in the strong coupling regime molecules near distant nanoparticles are coherently coupled.
RESUMO
BACKGROUND/OBJECTIVES: To predict the health economic consequences of modest reductions in the daily intake of salt (-1.0 g per day) and replacement of saturated fat (SFA, -1.0 energy percent (E%)) with polyunsaturated fat (PUFA, +1.0 E%) in the Finnish population aged 30-74 years. SUBJECTS/METHODS: A Markov model with dynamic population structure was constructed to present the natural history of cardiovascular diseases (CVDs) based on the most current information about the age- and sex-specific cardiovascular risk factors, dietary habits and nutrient intake. To predict the undiscounted future health economic consequences of the reduction of dietary salt and SFA, the model results were extrapolated for the years 2010-2030 by replacing the baseline population in the year 2007 with the extrapolated populations from the official Finnish statistics. Finnish costs (2009, societal perspective) and EQ-5D utilities were obtained from published references. RESULTS: During the next 20 years, a population-wide intervention directed at salt intake and dietary fat quality could potentially lead to 8000-13,000 prevented CVD cases among the Finnish adults compared the situation in year 2007. In addition, the reduced incidence of CVDs could gain 26,000-45,000 quality-adjusted life years and save 150-225 million over the same time period. CONCLUSION: A modest reduction of salt and replacement of SFA with PUFA in food products can significantly reduce the burden of CVD in the adult Finnish population. This impact may be even larger in the near future due to the ageing of Finnish population.
Assuntos
Dieta , Gorduras Insaturadas na Dieta/administração & dosagem , Ácidos Graxos/administração & dosagem , Comportamento Alimentar , Promoção da Saúde/economia , Cloreto de Sódio na Dieta/administração & dosagem , Adulto , Idoso , Doenças Cardiovasculares/prevenção & controle , Comportamento de Escolha , Simulação por Computador , Análise Custo-Benefício , Ingestão de Energia , Feminino , Finlândia , Preferências Alimentares , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Anos de Vida Ajustados por Qualidade de Vida , Fatores de RiscoRESUMO
We present real-space dynamical mean-field theory calculations for attractively interacting fermions in three-dimensional lattices with elongated traps. The critical polarization is found to be 0.8, regardless of the trap elongation. Below the critical polarization, we find unconventional superfluid structures where the polarized superfluid and Fulde-Ferrell-Larkin-Ovchinnikov-type states emerge across the entire core region.
RESUMO
OBJECTIVE: To compare national use of attention-deficit/hyperactivity disorder (ADHD) drugs between five Nordic countries. METHOD: A population-based drug utilisation study based on nationwide prescription databases, covering in total 24 919 145 individuals in 2007. ADHD drugs defined according to the World Health Organization Anatomic Therapeutic Chemical classification system as centrally acting sympathomimetics (N06BA). RESULTS: The 2007 prevalence of ADHD drug use among the total Nordic population was 2.76 per 1000 inhabitants, varying from 1.23 per 1000 in Finland to 12.46 per 1000 in Iceland. Adjusting for age, Icelanders were nearly five times more likely than Swedes to have used ADHD drugs (Prev.Ratio = 4.53, 95% CI: 4.38-4.69). Prevalence among boys (age 7-15) was fourfold the prevalence among girls (Prev.Ratio = 4.28, 95% CI: 3.70-4.96). The gender ratio was diminished among adults (age 21 +) (Prev.Ratio = 1.24, CI: 1.21-1.27). CONCLUSION: A considerable national variation in use of ADHD drugs exists between the Nordic countries.
Assuntos
Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Estimulantes do Sistema Nervoso Central/uso terapêutico , Uso de Medicamentos/estatística & dados numéricos , Simpatomiméticos/uso terapêutico , Adolescente , Adulto , Fatores Etários , Criança , Estudos Transversais , Bases de Dados Factuais , Feminino , Finlândia , Humanos , Islândia , Masculino , Pacientes Ambulatoriais , Padrões de Prática Médica/organização & administração , Padrões de Prática Médica/estatística & dados numéricos , Países Escandinavos e Nórdicos , Fatores SexuaisRESUMO
BACKGROUND: Rituximab induction together with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) and rituximab maintenance (RCHOP-R) resulted to significant progression-free survival (PFS) benefit in comparison to RCHOP in the EORTC20981 trial of relapsed/refractory follicular non-Hodgkin's lymphoma (FL). However, the overall survival (OS) difference between RCHOP-R and RCHOP was insignificant. This study evaluated the cost-effectiveness of RCHOP, RCHOP-R, and CHOP in the treatment of relapsed/refractory FL. DESIGN: A lifetime Markov modeling based on the 5-year EORTC20981 survivals (Weibull regressions) was carried out from the public health care payer perspective. Finnish costs (drug, routine, adverse event, and relapse management) were employed. The main outcomes were incremental cost (2008) per quality-adjusted life-year (QALY), progression-free year (PFY), and life-years gained (LYG). Analyses included cost-effectiveness acceptability frontier and multinomial expected value of perfect information (mEVPI). RESULTS: RCHOP-R resulted to OS (PFS) benefit compared with RCHOP and CHOP: 6 (10) and 17 (25) months, respectively. The incremental costs per QALY gained/LYG/PFY gained were 18 147/16 380/10 416 for RCHOP-R versus RCHOP (mEVPI 5196); 14 360/13 041/8976 for RCHOP-R versus CHOP (mEVPI 1986); and 12 123/11 049/8004 for RCHOP versus CHOP (mEVPI 1,240). RCHOP-R was the optimal option when the willingness to pay per QALY gained exceeded 18 399. CONCLUSION: RCHOP-R is a potentially cost-effective treatment option for the FL.
Assuntos
Anticorpos Monoclonais Murinos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Linfoma Folicular/tratamento farmacológico , Anticorpos Monoclonais Murinos/economia , Análise Custo-Benefício , Ciclofosfamida/uso terapêutico , Intervalo Livre de Doença , Doxorrubicina/uso terapêutico , Seguimentos , Custos de Cuidados de Saúde , Humanos , Estimativa de Kaplan-Meier , Linfoma Folicular/mortalidade , Cadeias de Markov , Prednisona/uso terapêutico , Qualidade de Vida , Recidiva , Rituximab , Resultado do Tratamento , Vincristina/uso terapêuticoRESUMO
We investigate the effect of optical lattices on the BCS superfluidity by using the Gorkov-Melik-Barkhudarov (GMB) correction for a two-component Fermi gas. We find that the suppression of the order parameter is strongly enhanced by the lattice effects. The predictions made by the GMB corrections are in qualitative and, for the cases studied, quantitative agreement with previous quantum Monte Carlo results. We discuss how the GMB correction extends the validity of the mean-field theory to a wider range of tunable optical lattice systems in different dimensions.
RESUMO
We study many-body contributions to the effective interaction between fermions in a three-component Fermi mixture. We find that effective interactions induced by the third component can lead to a phase diagram different from that predicted if interactions with the third component are neglected. As a result, in a confining potential a superfluid shell structure can arise even for equal populations of the components. We also find a critical temperature for the BCS transition in a 6Li mixture which can deviate strongly from the one in a weakly interacting two-component system.
RESUMO
We present phase diagrams for a polarized Fermi gas in an optical lattice as a function of temperature, polarization, and lattice filling factor. We consider the Fulde-Ferrel-Larkin-Ovchinnikov (FFLO), Sarma or breached pair, and BCS phases, and the normal state and phase separation. We show that the FFLO phase appears in a considerable portion of the phase diagram. The diagrams have two critical points of different nature. We show how various phases leave clear signatures to momentum distributions of the atoms which can be observed after time of flight expansion.
RESUMO
OBJECTIVE: The main objective was to estimate the mean direct costs of warfarin treatment for atrial fibrillation (AF) patients. Secondly, the costs of initiating warfarin treatment during a 60-day period and the impact of International Normalized Ratio (INR) and co-morbidities on costs were estimated. DESIGN AND DATA: The study was performed as a retrospective cohort study over a 12-month period in a Finnish communal health care setting. All AF patients aged 65 years or older (n = 250) with warfarin treatment were identified from the database of the health service district of an urban area. Patient specific information related to comorbidities, INR-control, complications and health care resource use were collected. Cost information was obtained from the Finnish national health care unit cost list. METHODS: The effect of treatment balance and other background variables on treatment costs were evaluated using ordinary least squares regression (OLS), log-transformed OLS and generalized linear model (GLM). The mean costs were calculated on the basis of the different models and bias corrected and accelerated (BCa) bootstrap confidence intervals (CIs) were calculated for the mean costs. RESULTS: The best fitting cost model was log-transformed OLS. The costs of warfarin treatment on the basis of the log-transformed model were 589.82 Euros (BCa 95% CI: 586.68-591.99) per patient compared to 616.00 Euros (BCa 95% CI: 579.98-652.96) obtained with the OLS-model. For the treatment initiation period, the mean costs were 263 Euros (BCa 95% CI: 218.90-314.71). Depending on the way that INR-control was defined, the mean costs were 95.27 Euros or 166.92 Euros higher for patients who were not in the defined INR-balance. CONCLUSIONS: The INR-control has a significant impact on the warfarin treatment costs. The choice of model influences the estimated mean costs. In addition, different models identify statistically significant effects between different background variables and costs.
Assuntos
Anticoagulantes/economia , Fibrilação Atrial/tratamento farmacológico , Custos de Cuidados de Saúde/estatística & dados numéricos , Atenção Primária à Saúde/economia , Serviços Urbanos de Saúde/economia , Varfarina/economia , Idoso , Idoso de 80 Anos ou mais , Anticoagulantes/uso terapêutico , Fibrilação Atrial/complicações , Custos Diretos de Serviços/estatística & dados numéricos , Custos de Medicamentos/estatística & dados numéricos , Feminino , Finlândia , Humanos , Coeficiente Internacional Normatizado , Masculino , Modelos Estatísticos , Estudos Retrospectivos , Resultado do Tratamento , Varfarina/uso terapêuticoRESUMO
We study a quasi-two-dimensional superfluid Fermi gas where the confinement in the third direction is due to a strong harmonic trapping. We investigate the behavior of such a system when the chemical potential is varied and find strong modifications of the superfluid properties due to the discrete harmonic oscillator states. We show that such quasi-two-dimensional behavior can be created and observed with current experimental capabilities.
RESUMO
We study the nonlinear excitations of a vortex line in a Bose-Einstein condensate trapped in a one-dimensional optical lattice. We find that the classical Euler dynamics of the vortex results in a description of the vortex line in terms of a (discrete) one-dimensional Gross-Pitaevskii equation, which allows for both bright and gray soliton solutions. We discuss these solutions in detail and predict that it is possible to create vortex-line solitons with current experimental capabilities.
RESUMO
Using a variational ansatz for the wave function of the Bose-Einstein condensate, we develop a quantum theory of vortices and quadrupole modes in a one-dimensional optical lattice. We study the coupling between the quadrupole modes and Kelvin modes, which turns out to be formally analogous to the theory of parametric processes in quantum optics. This leads to the possibility of squeezing vortices. We solve the quantum multimode problem for the Kelvin modes and quadrupole modes numerically and find properties that cannot be explained with a simple linear-response theory.
RESUMO
We propose a method to create a monopole structure in a multicomponent condensate by applying the basic methods used to create vortices and solitons experimentally in single-component condensates. We also show that by using a two-component structure for a monopole, we can avoid many problems related to the previously suggested three-component monopole. We discuss the observation and dynamics of such a monopole structure, and note that the dynamics of the two-component monopole differs from the dynamics of the three-component monopole.